Ranolazine, a new anti-anginal agent is a piperazine derivative, for treatment of chronic stable angina pectoris as combination therapy when angina is not adequately controlled with conventional drugs.
Biochemical markers in acute coronary syndrome: Troponin: high sensitivity and specificity, CK-MB: better re-infarction, myoglobin: for rapid diagnosis.
Apple-type and pear-type obesity: Marked adverse metabolic consequences are seen with central (android or apple-type), but rarely with gluteo-femoral (gynoid or pear-type) obesity.